Quantcast
Home > Quotes > HALO
HALO

Halozyme Therapeutics, Inc. Common Stock (HALO) Quote & Summary Data

$16.13
*  
0.07
0.43%
Get HALO Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading HALO now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
21
Today's High / Low
$ 16.33 / $ 15.70
Share Volume
558,922
50 Day Avg. Daily Volume
904,802
Previous Close
$ 16.20
52 Week High / Low
$ 21.48 / $ 14.33
Market Cap
2,331,713,169
P/E Ratio
52.03
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ 0.31
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.4

Intraday Chart

Shares Traded

Share Volume:
558,922
50 Day Avg. Daily Volume:
904,802

P/E Ratio

P/E Ratio:
52.03
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ 0.31

Trading Range

The current last sale of $16.13 is 12.56% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 16.33 $ 21.48
 Low: $ 15.70 $ 14.33

Company Description (as filed with the SEC)

Halozyme Therapeutics, Inc. is a biotechnology company focused on developing and commercializing novel oncology therapies. We are seeking to translate our unique knowledge of the tumor microenvironment to create therapies that have the potential to improve cancer patient survival. Our research primarily focuses on human enzymes that alter the extracellular matrix and tumor microenvironment. The extracellular matrix is a complex matrix of proteins and carbohydrates surrounding the cell that provides structural support in tissues and orchestrates many important biological activities, including cell migration, signaling and survival. Over many years, we have developed unique technology and scientific expertise enabling us to pursue this target-rich environment for the development of therapies.  ... More ...  


Risk Grade

Where does HALO fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 16.09
Open Date:
Nov. 16, 2018
Close Price:
$ 16.20
Close Date:
Nov. 16, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x